%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/2162402X.2018.1542917
Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells
Ahdab Alsaieedi
Angelika Holler
Pedro Velica
Gavin Bendle
Hans J. Stauss
Taylor & Francis
OncoImmunology, 2019. doi:10.1080/2162402X.2018.1542917
Immunotherapy
TCR
IL-12
T cells
adoptive
engineering
NFAT
Tet
en
Journal
OncoImmunology
© 2018 The Author(s). Published with license by Taylor & Francis Group, LLC
2162-402X
8
3
1
11
10.1080/2162402X.2018.1542917
https://doi.org/10.1080/2162402X.2018.1542917
VoR
application/pdfdoi:10.1080/2162402X.2018.154291710.1080/2162402X.2018.1542917https://doi.org/10.1080/2162402X.2018.15429172018-12-05truewww.tandfonline.com10.1080/2162402X.2018.1542917www.tandfonline.comtrue2018-12-0510.1080/2162402X.2018.1542917
endstream
endobj
4 0 obj
<>stream
xYK$5 7`$p`@˅IvhU[y8~~v<`^5N@єm g~9<>\c6<ۡ
>j2bkUl9\>=Gp6 kGy;8Z㲇~auzsFs.>]CÜc'fA]~<}%Z
R+
QK"=*:'}Lt*wW%=ofaՀPܩB9x3<5Y}K+|'>QR*G8|Wl>^;' }EtK,@jgC^~-?a͟|w+1brGLhH'_r,eF#ݛ| a>[p8ˢܵjEDMjݞXl|*sʙPT-P 3,'ys>.lz˃+E OW> l½pߎQd<9OBK/
8pL1y/g